Cargando…
Role of Cytochrome P450 2C9 in COVID-19 Treatment: Current Status and Future Directions
The major human liver drug metabolising cytochrome P450 (CYP) enzymes are downregulated during inflammation and infectious disease state, especially during coronavirus disease 2019 (COVID-19) infection. The influx of proinflammatory cytokines, known as a ‘cytokine storm’, during severe COVID-19 lead...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123480/ https://www.ncbi.nlm.nih.gov/pubmed/37093458 http://dx.doi.org/10.1007/s13318-023-00826-8 |